Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPROPION\NALTREXONE Cause Therapeutic product effect variable? 5 Reports in FDA Database

Lose Weight Fast — The 21-Day Smoothie Diet

36 fat-burning recipes + shopping lists. Results in the first week.

Get the Program

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapeutic product effect variable have been filed in association with BUPROPION\NALTREXONE. This represents 0.1% of all adverse event reports for BUPROPION\NALTREXONE.

5
Reports of Therapeutic product effect variable with BUPROPION\NALTREXONE
0.1%
of all BUPROPION\NALTREXONE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Therapeutic product effect variable From BUPROPION\NALTREXONE?

Of the 5 reports, 1 (20.0%) required hospitalization.

Is Therapeutic product effect variable Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPROPION\NALTREXONE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does BUPROPION\NALTREXONE Cause?

Nausea (1,857) Headache (1,054) Dizziness (986) Vomiting (646) Constipation (602) Feeling abnormal (550) Fatigue (474) Anxiety (378) Insomnia (367) Diarrhoea (350)

What Other Drugs Cause Therapeutic product effect variable?

CARBIDOPA\LEVODOPA (316) LEVODOPA (298) RIMEGEPANT (177) GABAPENTIN (166) CLOZAPINE (157) DICLOFENAC (153) OLANZAPINE (150) FLUOXETINE (149) ARIPIPRAZOLE (148) AMISULPRIDE (147)

Which BUPROPION\NALTREXONE Alternatives Have Lower Therapeutic product effect variable Risk?

BUPROPION\NALTREXONE vs BUROSUMAB BUPROPION\NALTREXONE vs BUROSUMAB-TWZA BUPROPION\NALTREXONE vs BUSPIRONE BUPROPION\NALTREXONE vs BUSULFAN BUPROPION\NALTREXONE vs BUSULFEX

Related Pages

BUPROPION\NALTREXONE Full Profile All Therapeutic product effect variable Reports All Drugs Causing Therapeutic product effect variable BUPROPION\NALTREXONE Demographics